Cytokinetics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Cytokinetics and other ETFs, options, and stocks.

About CYTK

Cytokinetics, Inc. is a biopharmaceutical company, which is focused on discovering, developing, and commercializing muscle activators and muscle inhibitors as potential treatments for people with debilitating diseases in which muscle performance is compromised and/or declining. The firm is developing small molecule drug candidates specifically engineered to impact muscle function and contractility. 

CEO
Robert I. Blum
CEORobert I. Blum
Employees
498
Employees498
Headquarters
South San Francisco, California
HeadquartersSouth San Francisco, California
Founded
1997
Founded1997
Employees
498
Employees498

CYTK Key Statistics

Market cap
3.88B
Market cap3.88B
Price-Earnings ratio
-6.11
Price-Earnings ratio-6.11
Dividend yield
Dividend yield
Average volume
1.48M
Average volume1.48M
High today
$33.17
High today$33.17
Low today
$32.07
Low today$32.07
Open price
$32.81
Open price$32.81
Volume
2.32M
Volume2.32M
52 Week high
$61.38
52 Week high$61.38
52 Week low
$29.31
52 Week low$29.31

CYTK News

Investing.com 5d
Cytokinetics CEO Robert Blum sells $169,000 in stock - Investing.com

...

Cytokinetics CEO Robert Blum sells $169,000 in stock - Investing.com

Analyst ratings

86%

of 22 ratings
Buy
86.4%
Hold
13.6%
Sell
0%

People also own

Based on the portfolios of people who own CYTK. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.